«The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admission» – Clinical and translational medicine – Oct 2021 – José Avendaño-Ortiz 1 2, Roberto Lozano-Rodríguez 1 2, Alejandro Martín-Quirós 3, Verónica Terrón 1 2, Charbel Maroun-Eid 2, Karla Montalbán-Hernández 1 2, Jaime Valentín-Quiroga 1 2, Miguel Ángel García-Garrido 3, Elena Muñoz Del Val 1 3, Álvaro Del Balzo-Castillo 1 3, María Peinado 3, Laura Gómez 3, Carmen Herrero-Benito 3, Carolina Rubio 1 2, José Carlos Casalvilla-Dueñas 1 2, Paloma Gómez-Campelo 1 4, Alejandro Pascual-Iglesias 1 2, Carlos Del Fresno 1 2, Luis A Aguirre 1 2, Eduardo López-Collazo 1 2 5 No abstract available Read more Categorías: COVID-19, PublicationsPor Carlos del Fresnooctubre 15, 2021Deja un comentarioEtiquetas: Candida albicansdectin-1innate immunitysignalingtrained immunityNavegación entre publicacionesAnteriorPublicación anterior:Soluble SIGLEC5: A New Prognosis Marker in Colorectal Cancer PatientsSiguientePublicación siguiente:SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdownRelated PostsEndotoxin tolerance and trained immunity: breaking down immunological memory barriersmayo 1, 2024Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studymayo 15, 2022
Heat-killed Mycobacterium tuberculosis induces trained immunity in vitro and in vivo administered systemically or intranasallyenero 31, 2024
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lungoctubre 9, 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsabril 24, 2023
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumorsjulio 1, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studymayo 15, 2022
